Gharpure, Anant
Sulpizio, Ariana
Loeffler, Johannes R.
Fernández-Quintero, Monica L.
Tran, Andy S. https://orcid.org/0009-0004-0508-6015
Lairson, Luke L. https://orcid.org/0000-0001-6701-996X
Ward, Andrew B. https://orcid.org/0000-0001-7153-3769
Funding for this research was provided by:
California Institute for Regenerative Medicine (EDUC4-12811)
Article History
Received: 2 August 2024
Accepted: 31 March 2025
First Online: 11 April 2025
Competing interests
: L.L.L. is an inventor on patents that describe the discovery of synthetic STING agonists. The four patents are as follows: “Agonists of Stimulator of Interferon Genes STING” Petrassi, M. Lairson, L.L., Chin, E., Schultz, P.G., Yu, C., Yang, B., Heather, V., Grant, S., Li, Y, Pacheco, A., Chu, A. Johnson, K. Chatterjee, A. U.S. Patent Application 62/706,683. September 2, 2020.“Bicyclic agonists of stimulator of interferon genes sting” Petrassi, M. Yu, C., Wang, J., Chatterjee, Schultz, P.G., Johnson, K., Chu, A., Chin, E., Lairson, L.L. U.S. Patent Application 62/889,679. August 21, 2019.“Monocyclic agonists of stimulator of interferon genes sting” Petrassi, M., Yu, C., Wang, J., Chatterjee, A. Yu, C., Chatterjee, A. Gamo Albero, A.M., Gupta, A., Tamiya, J., Schultz, P.G., Johnson, K., Chu, A., Chin, E., Lairson, L.L. U.S. Patent Application 62/889,669. August 9, 2020.“6(1H-imidazolyl)pyridazine compounds as agonists of stimulator of interferon genes sting” Lairson, L.L., Chin, E., Chatterjee, A., Kumar, M., Gamo Albero, A., Petrassi, M., Schultz, P., Yu, C., Tamiya, J., Vernier, W., Gupta, A. Modukuri, R. US Patent Application 62/633,409. February 21, 2018.The remaining authors declare no competing interests.